Jean‑laurent Casanova - Infectious Diseases

Author Information

Jean-Laurent Casanova is a distinguished researcher affiliated with the St. Giles Laboratory of Human Genetics of Infectious Diseases, Rockefeller Branch, at The Rockefeller University in New York. His work predominantly focuses on the genetic aspects of infectious diseases, contributing significantly to the understanding of human immune response to various pathogens.

Research Contributions

Jean-Laurent Casanova has made substantial contributions to the field of immunology and infectious diseases, with a particular focus on inborn errors of immunity. In 2022, his work covered a wide range of topics including the genetic determinants of cutaneous lesions, the role of type I interferons in SARS-CoV-2 infections, and the impact of autoantibodies in COVID-19 fatalities. His research also extends to understanding the pathogenesis of serious viral infections in individuals with specific genetic deficiencies, and the immunological profiles of conditions like multisystem inflammatory syndrome in children (MIS-C).

Aliases

Jean-Laurent Casanova is known by various aliases in the academic community, including J-l Casanova, J L Casanova, and Jean L. Casanova, among others. These variations often appear in different publications and citations.

Publication and Citation Metrics

Metric	Value
Total Citation Count	90,130
H-index	152
Total Paper Count	1,148

Publications:

Inborn Errors of Immunity in Algerian Children and Adults: A Single-Center Experience Over a Period of 13 Years (2008–2021)

DOI: 10.3389/fimmu.2022.900091

Year: 2022

The Pathogenesis of Giant Condyloma Acuminatum (Buschke-Lowenstein Tumor): An Overview

DOI: 10.3390/ijms23094547

Year: 2022

Whole-transcriptome sequencing-based concomitant detection of viral and human genetic determinants of cutaneous lesions.

DOI: 10.1172/jci.insight.156021

Year: 2022

Type I interferons and SARS-CoV-2: from cells to organisms

DOI: 10.1016/j.coi.2022.01.003

Year: 2022

The risk of infections for multiple sclerosis and neuromyelitis optica spectrum disorder disease-modifying treatments: Eighth European Committee for Treatment and Research in Multiple Sclerosis Focused Workshop Review. April 2021.

DOI: 10.1177/13524585211069068

Year: 2022

Autoantibodies Neutralizing Type I Interferons in 20% of COVID-19 Deaths in a French Hospital

DOI: 10.1007/s10875-021-01203-3

Year: 2022

Correction to: Life-Threatening Enterovirus 71 Encephalitis in Unrelated Children with Autosomal Dominant TLR3 Deficiency.

DOI: 10.1007/s10875-022-01259-9

Year: 2022

A loss-of-function IFNAR1 allele in Polynesia underlies severe viral diseases in homozygotes.

DOI: 10.1084/jem.20220028

Year: 2022

TIM3+ TRBV11-2 T cells and IFNγ signature in patrolling monocytes and CD16+ NK cells delineate MIS-C

DOI: 10.1084/jem.20211381

Year: 2022

Human autoantibodies underlying infectious diseases

DOI: 10.1084/jem.20211387

Year: 2022

What is the impact of climate change on infectious diseases?

Can Glycolysis Be a Therapeutic Target?

What is the Role of Centers for Disease Control and Prevention?

How Can Education Help in the Prevention of Infectious Diseases?

How Does Globalization Affect Infectious Disease Spread?

What are Antimicrobial Therapies?

How Do Imaging Tests Aid in Treatment?

What are Some Disorders Involving B Cells?

What Role Do Respiratory Droplets Play in Super-Spreading Events?

What Research is Being Conducted?

Partnered Content Networks

Relevant Topics